Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial respiratory chain enzymes are a set of membrane-bound protein complexes and associated electron carriers that drive oxidative phosphorylation in mycobacteria, including *Mycobacterium tuberculosis* (Mtb). These enzymes are essential for energy production, redox balance, and survival of the pathogen. The respiratory chain is highly branched and includes several key complexes: NADH dehydrogenase (Complex I), succinate dehydrogenase (Complex II), cytochrome bc1-aa3 supercomplex (Complex III-IV), cytochrome bd oxidase, and various quinones such as menaquinone. Nitric oxide (NO) produced by host immune cells can inhibit or damage components of the mycobacterial respiratory chain. Mtb has evolved mechanisms to evade or resist NO-mediated inhibition.
Inhibition of electron transport chain complexes, disruption of ATP synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial Respiratory Chain Enzymes.